These results suggest that the tumor milieu created by IDO-positive NPC cells could significantly impair the cytolytic function of activated lymphocytes, providing a potential mechanism for immune evasion in patients with NPC. This evidence concerns the gene IDO1 and nasopharyngeal carcinoma.